Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
Cancer Lett. 2010 Nov 28;297(2):171-81. doi: 10.1016/j.canlet.2010.05.009. Epub 2010 Jun 14.
Aurora-A (Aur-A) is a centrosome-associated serine/threonine kinase that is overexpressed in various cancers and potentially correlated with chemoresistance. In the Ara-C-sensitive leukemia cell lines, silencing of Aur-A by small interfering RNA transfection led to a significant increase in the Ara-C-induced cell death rate through induction of mitochondria-mediated, caspase-dependent apoptosis. In contrast, combined treatment of the Ara-C-resistant leukemia cell lines with Aur-A siRNA and Ara-C remarkably enhanced the cell death rate via non-caspase-dependent mitotic catastrophe. Taken together, Aur-A inhibition was an effective treatment for both the Ara-C-sensitive and resistant leukemia cells by increasing apoptosis and mitotic catastrophe, respectively.
极光激酶 A(Aurora-A)是一种与中心体相关的丝氨酸/苏氨酸激酶,在各种癌症中过度表达,并可能与化疗耐药性相关。在阿糖胞苷敏感的白血病细胞系中,通过小干扰 RNA 转染沉默 Aur-A 导致阿糖胞苷诱导的细胞死亡率显著增加,这是通过诱导线粒体介导的 caspase 依赖性细胞凋亡实现的。相比之下,在阿糖胞苷耐药的白血病细胞系中, Aur-A siRNA 和阿糖胞苷的联合治疗通过非 caspase 依赖性有丝分裂灾难显著增加了细胞死亡率。总之,通过分别增加细胞凋亡和有丝分裂灾难,极光激酶 A 的抑制作用是治疗阿糖胞苷敏感和耐药白血病细胞的有效方法。